HeXun Biosciences Co., Ltd.
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
HeXun’s offerings include allogeneic mesenchymal‑stem‑cell drugs, contract development and manufacturing services (CDMO/CMO), sterile‑filling services, cell and derivative testing and consulting, and a laboratory information‑management system — supported
Founded Year
2019
Unified Business No.
50924393
Status
Active
Number of Employees
46
Total Paid-in
Capital
460,000,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Exit Status
Emerging Stock Exchange(2023)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
HeXun Biosciences Co., Ltd., founded in 2019, is a biotechnology company dedicated to stem‑cell research and therapy, aiming to transform cutting‑edge cellular technologies into high‑quality medical solutions under its core philosophy “LIVE LONG, HEALTHY
